natgillin/translations-raw huggingface dataset:
Reactions like restlessness, agitation, irritability, aggressiveness, abnormal thinking, delusion, rages, nightmares, depersonalisation, hallucinations, psychoses, inappropriate behaviour, extroversion that seems out of character and other behavioural effects have been reported following use of any medicines belonging to the sleep inducing group, including Zerene.
On teada, et und tekitavaid ravimeid, sh Zerene’t kasutavatel patsientidel esineb rahutust, agiteeritust, ärritatavust, agressiivsust, ebanormaalseid mõtteid, meelepetteid, raevuhooge, luupainajaid, depersonalisatsiooni, hallutsinatsioone, psühhoose, ebanormaalset käitumist, antud isiku iseloomule ebatüüpilist ekstroversiooni ning teisi käitumishäireid.
Reactions like restlessness, agitation, irritability, decreased inhibition, aggressiveness, abnormal thinking, delusions, rages, nightmares, depersonalisation, hallucinations, psychoses, inappropriate behaviour, extroversion that seems out of character and other adverse behavioural reactions are known to occur when using benzodiazepines or benzodiazepine-like agents.
On teada, et bensodiasepiine ja bensodiasepiinidele sarnaseid ravimeid kasutavatel patsientidel esineb rahutust, agiteeritust, ärritatavust, pidurdamatust, agressiivsust, ebanormaalseid mõtteid, meelepetteid, raevuhooge, luupainajaid, depersonalisatsiooni, hallutsinatsioone, psühhoose, ebanormaalset käitumist, antud isiku iseloomule ebatüüpilist ekstroversiooni ning teisi käitumishäireid.
Reactions like restlessness, agitation, irritability, decreased inhibition, aggressiveness, abnormal thinking, delusions, rages, nightmares, depersonalisation, hallucinations, psychoses, inappropriate behaviour, extroversion that seems out of character, and other adverse behavioural reactions are known to occur when using benzodiazepines or benzodiazepine-like agents.
On teada, et bensodiasepiine ja bensodiasepiinidele sarnaseid ravimeid kasutavatel patsientidel esineb rahutust, agiteeritust, ärritatavust, pidurdamatust, agressiivsust, ebanormaalseid mõtteid, meelepetteid, raevuhooge, luupainajaid, depersonalisatsiooni, hallutsinatsioone, psühhoose, ebanormaalset käitumist, antud isiku iseloomule ebatüüpilist ekstroversiooni ning teisi käitumishäireid.
Reactions might include wheezing (bronchospasm), badly blocked nose, itchy skin, rash or swelling of the face, lips or tongue, other allergic reactions or nasal polyps after taking these medicines
Reaktsioonide hulka võivad kuuluda pärast ravimi võtmist tekkiv vilistav hingamine (bronhospasm), tugevalt kinnine nina, naha sügelemine, lööve või näo, huulte või keele turse, teised allergilised reaktsioonid või ninapolüübid
Reactions observed from the postmarketing environment
Turuletulekujärgselt esinenud kõrvaltoimed
Reactions observed in Pivotal and Supportive Clinical Trials (in 642 patients)
Kõrvaltoimed, mis esinesid kliinilistes uuringutes (642 patsienti)
Reactions of Grade 3 or 4 severity occurred in 5.0% of lenvatinib-treated vs 0 placebo-treated patients.
3. või 4. raskusastmega kõrvaltoimeid tekkis 5,0% lenvatiniibiga ravitud patsientidest vs 0 platseeboga ravitud patsientidest.
Reactions of Grade 3 or higher (including
3. või kõrgema astme nähte (sealhulgas üks
Reactions of not known frequency (frequency cannot be estimated from the available data)
Teadmata sagedusega reaktsioonid (sagedust ei saa hinnata olemasolevate andmete alusel)
reactions of tricyclic antidepressants is recommended (see section 4.4).
Soovitatav on tritsükliliste antidepressantide ravi- ja kõrvaltoimete hoolikas jälgimine (vt lõik 4.4).
Reactions related to volume depletion (including, reports of dehydration, hypovolaemia or hypotension) were reported in 1.1% and 0.7% of subjects who received dapagliflozin 10 mg and placebo, respectively; serious reactions occurred in < 0.2% of subjects balanced between dapagliflozin 10 mg and placebo (see section 4.4).
Ringleva vere mahu vähenemisega seotud reaktsioone (sh dehüdratsiooni, hüpovoleemia või hüpotensiooni teated) registreeriti dapagliflosiini 10 mg annuse puhul 1,1%-l ja platseebo puhul 0,7%- l isikutest; raskeid reaktsioone esines <0,2%-l isikutest ning neid esines võrdselt 10 mg dapagliflosiini ja platseebo grupis (vt lõik 4.4).
Reactions reported in the post-marketing setting are listed with frequency not known (cannot be estimated from the available data).
Turustamisjärgsetel teadetel on esinemissageduseks märgitud teadmata (ei saa hinnata olemasolevate andmete alusel).
reactions such as
näiteks Stevensi
Reactions such as cough, pyrexia, headache, P. falciparum infection, anaemia, asthenia, anorexia and the observed changes in blood cell parameters are consistent with those expected in patients with acute malaria.
Kõrvalnähud nagu köha, püreksia, peavalu, P. falciparum’i põhjustatud infektsioon, aneemia, asteenia, anoreksia ja täheldatud muutused vererakkude parameetrites vastavad ägeda malaariaga patsientide eeldatavatele nähtudele.
Reactions suggestive of immediate (Type I) hypersensitivity have been reported in a small number of patients (see section 4.4).
Väikesel arvul patsientidel on tatatud reaktsioonidest, mis viitavad otsesele (I tüüpi) ülitundlikkusele (vt lõik 4.4).
Reactions were reported at various time points during treatment ranging from one week to greater than 1 year from initiation of Avastin, with most reactions occurring within the first 6 months of therapy.
Fistulid on tekkinud erinevatel ajahetkedel ravi ajal: üks nädal kuni rohkem kui aasta pärast Avastin-ravi alustamist; kõige sagedamini on fistulid tekkinud esimese 6 ravikuu jooksul.
Reactions where the injection was given such as bruising, a hard lump, itching, warmth
Reaktsioonid süstekohas, näiteks verevalum, kõva tükk, sügelemine, kuumatunne
reactions,
reaktsioonid,
reactions:
reaktsioonid:
reactivation of hepatitis B
B-hepatiidi reaktiveerumine
reactivation of hepatitis B
hepatiit B reaktivatsioon
Reactivation of hepatitis B (HBV) in patients who are chronic carriers of this virus has occurred after these patients received BCR-ABL tyrosine kinase inhibitors.
Patsientidel, kes on B-hepatiidi (HBV) viiruse kroonilised kandjad, on pärast BCR-ABL türosiinkinaasi inhibiitorite manustamist tekkinud selle reaktiveerumine.
Reactivation of hepatitis B has occurred in patients receiving a TNF-antagonist including certolizumab pegol, who are chronic carriers of this virus (i.e., surface antigen positive).
Hepatiit B reaktivatsiooni on esinenud patsientidel, kes on selle viiruse kroonilised kandjad (st pinnaantigeen-positiivne) ja saavad TNF-antagoniste, sh tsertolizumab pegooli.
Reactivation of hepatitis B has occurred in patients receiving a TNF-antagonist including Humira, who are chronic carriers of this virus (i.e. surface antigen positive).
Hepatiit B reaktivatsiooni on esinenud TNF-antagoniste, sh Humira’t saavatel patsientidel, kes on selle viiruse kroonilised kandjad (st pinnaantigeen positiivne),.
Reactivation of hepatitis B has occurred in patients receiving a TNF-antagonist including Humira, who are chronic carriers of this virus (i.e. surface antigen positive).
Hepatiit B reaktivatsiooni on esinenud TNF-antagoniste, sh Humira’t saavatel patsientidel, kes on selle viiruse kroonilised kandjad (st pinnaantigeen positiivne).
Reactivation of hepatitis B has occurred in patients receiving a TNF-antagonist including Simponi, who are chronic carriers of this virus (i.e. surface antigen positive).
Hepatiit B reaktivatsiooni on esinenud patsientidel, kes on selle viiruse kroonilised kandjad (st pinnaantigeen-positiivne) ja saavad TNF-i antagoniste, sh Simponit.
Reactivation of hepatitis B has occurred in patients receiving a TNF-antagonist including Trudexa, who are chronic carriers of this virus.
Hepatiit B reaktivatsiooni on esinenud TNF-antagoniste, sh Trudexa’t saavatel patsientidel, kes on selle viiruse kroonilised kandjad.
Reactivation of hepatitis B in patients who are chronic carriers of this virus has occurred after these patients received BCR-ABL tyrosine kinase inhibitors.
Esinenud on B-hepatiidi reaktiveerumist viirust krooniliselt kandvatel patsientidel pärast BCR-ABL- türosiinkinaasiinhibiitorite kasutamist.
Reactivation of hepatitis B in patients who are chronic carriers of this virus has occurred after these patients received BCR-ABL tyrosine kinase inhibitors.
On esinenud B-hepatiidi reaktiveerumist viirust krooniliselt kandvatel patsientidel pärast BCR-ABL- türosiinkinaasiinhibiitorite kasutamist.
Reactivation of hepatitis B infection has also been very rarely reported in RA patients receiving MabThera (see Section 4.4).
B-hepatiidi infektsiooni reaktiveerumist on väga harva kirjeldatud ka MabThera’t saanud reumatoidartriidiga patsientidel (vt lõik 4.4).
Reactivation of hepatitis B infection has also been very rarely reported in rheumatoid arthritis patients receiving MabThera (see Section 4.4).
B-hepatiidi infektsiooni reaktiveerumist on väga harva kirjeldatud ka MabThera’t saanud reumatoidartriidiga patsientidel (vt lõik 4.4).
reactivation of hepatitis B virus if you are a carrier or have had hepatitis B before (rare).
B-hepatiidi viiruse taasaktiveerumine, kui te olete nakkusekandja või teil on varem olnud B-hepatiit (harv).
Reactive airway disease including bronchial asthma or a history of bronchial asthma, or severe chronic obstructive pulmonary disease.
Reaktiivne hingamisteede haigus, sh bronhiaalastma või varem põetud bronhiaalastma, või raske krooniline obstruktiivne kopsuhaigus.
Reactive airway disease including bronchial asthma or a history of bronchial asthma, severe chronic obstructive pulmonary disease.
Reaktiivne hingamisteede haigus, sh bronhiaalastma või selle olemasolu varasemas anamneesis või raske krooniline obstruktiivne kopsuhaigus.
Read across on the same line to see how many film-coated tablets to take.
Samalt realt loe, mitu õhukese polümeerikattega tabletti võtta.
Read all instructions thoroughly before using the pre-filled syringe.
Enne süstli kasutamist lugege hoolikalt kõiki juhiseid.
Read all of these instructions before using your pen.
Enne pensüstli kasutamist lugege kasutusjuhiseid.
Read all of this le afle t care fully before you start taking this me dicine .
Enne ravimi võtmist lugege hoolikalt infole hte.
Read all of this le afle t carefully before you start taking this medicine because it contains important information for you.
Enne ravimi võtmist lugege hoolikalt infole hte, sest siin on teile vajalikku teavet.
Read all of this le afle t carefully before you start taking this medicine.
Enne ravimi võtmist lugege hoolikalt infole hte.
Read all of this leaflet carefully before starting to use your insulin inhaler Keep this leaflet.
Enne insuliiniinhalaatori kasutamist lugege hoolikalt käesolevat infolehte.
Read all of this leaflet carefully before you are given this medicine because it contains important information for you or your child.
Enne ravimi saamist lugege hoolikalt infolehte, sest siin on teile või teie lapsele vajalikku teavet.
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
Enne kui teile ravimit antakse lugege hoolikalt infolehte, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before you are giventhis medicine because it contains important information for you.
Enne ravimi võtmist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before you or your child are vaccinated because it contains important information for you or your child.
Enne teie või teie lapse vaktsineerimist lugege hoolikalt infolehte, sest siin on teile või teie lapsele vajalikku teavet.
Read all of this leaflet carefully before you start taking this because it contains important information for you.
Enne ravimi võtmist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet
Read all of this leaflet carefully before you start taking this medicine - because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you or your child.
Enne ravimi võtmist lugege hoolikalt infolehte, sest siin on teile ja teie lapsele vajalikku teavet.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, sest siin on teile kasulikku teavet.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Enne ravimi võtmist lugege hoolikalt infoleht, sest siin on teile vajalikku teavet e.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Enne ravimi võtmist lugege hoolikalt infolehte, sest sii on teile vajalikku teavet.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Enne ravimi võtmist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Enne ravimi võtmist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet..
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Enne ravimi võtmist lugege hoolikalt infolehte, sest siin võib olla teile vajalikku teavet.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Enne ravimi võtmist lugege hoolikaltb infolehte, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Lugege infolehte hoolikalt, sest siin on teile vajalikku teavet, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you..
Enne ravimi võtmist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before you start taking this medicine because it contains important information foryou.
Enne ravimi võtmist lugege hoolikalt infolehte, sestsiin on teile vajalikku teave t.
Read all of this leaflet carefully before you start taking this medicine because it contains important information foryou.
Enne ravimi võtmist lugege hoolikalt infolehte, sestsiin on teile vajalikku teavet.
Read all of this leaflet carefully before you start taking this medicine medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before you start taking this medicine.
Enne ravimi võtmist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before you start taking this medicine.
Epoetiin delta Enne ravimi kasutamist lugege hoolikalt infolehte.
Read all of this leaflet carefully before you start using Kentera
Enne Kentera kasutamist lugege hoolikalt infolehte.
Read all of this leaflet carefully before you start using this medicine
Enne ravimi kasutamist lugege hoolikalt infolehte.
Read all of this leaflet carefully before you start using this medicine because it contains important information for you
Enne ravimi kasutamist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kuna see sisaldab teie jaoks olulist teavet.
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, sest see sisaldab teie jaoks vajalikku teavet.
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte.
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege kogu käesolev infoleht hoolikalt läbi, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before you start using this medicine because it contains important information for you..
Enne ravimi kasutamist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before you start using this medicine because it contains important information.
Enne ravimi kasutamist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before you start using this medicine because it contains information important for you
Enne ravimi kasutamist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before you start using this medicine becsue it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before you start using this medicine.
Enne ravimi kasutamist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully before your child starts taking this medicine because it contains important information for your child.
Enne ravimi kasutamist lugege hoolikalt infolehte, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for Use of Apidra, pre-filled pen, OptiSet before using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, sealhulgas Apidra eeltäidetud pensüstli OptiSet kasutusjuhendit, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for Use of Insuman Basal SoloStar, pre-filled pen, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasaarvatud Insuman Basal SoloStar eeltäidetud pen-süstli kasutusjuhendit, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for use of Insuman Basal, pre-filled pen, OptiSet, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasaarvatud Insuman Basal eeltäidetud pen-süstli OptiSet kasutusjuhendit, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for Use of Insuman Comb 15 SoloStar, pre-filled pen, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasaarvatud Insuman Comb 15 SoloStar eeltäidetud pen-süstli kasutusjuhendit, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for use of Insuman Comb 15, pre-filled pen, OptiSet, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasaarvatud Insuman Comb 15 eeltäidetud pen-süstli OptiSet kasutusjuhendit, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for Use of Insuman Comb 25 SoloStar, pre-filled pen, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasaarvatud Insuman Comb 25 SoloStar, eeltäidetud pen-süstli, kasutusjuhendit, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for use of Insuman Comb 25, pre-filled pen, OptiSet, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasaarvatud Insuman Comb 25 eeltäidetud pen-süstli OptiSet kasutusjuhendit, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for Use of Insuman Comb 30 SoloStar, pre-filled pen, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasaarvatud Insuman Comb 30 SoloStar, eeltäidetud pen-süstli kasutusjuhendit, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for use of Insuman Comb 30, pre-filled pen, OptiSet, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasaarvatud Insuman Comb 30 eeltäidetud pen-süstli OptiSet kasutusjuhendit, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for Use of Insuman Comb 50 SoloStar, pre-filled pen, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasarvatud Insuman Comb 50 SoloStar, eeltäidetud pen-süstli kasutusjuhendit, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for use of Insuman Comb 50, pre-filled pen, OptiSet, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasarvatud Insuman Comb 50 eeltäidetud pen-süstli OptiSet kasutusjuhendit, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for Use of Insuman Rapid SoloStar, pre-filled pen, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasaarvatud Insuman Rapid SoloStar eeltäidetud pen-süstli kasutusjuhendit, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for use of Insuman Rapid, pre-filled pen, OptiSet, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasaarvatud Insuman Rapid OptiSet eeltäidetud pen-süstli OptiSet kasutusjuhendit, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for Use of Lantus OptiSet, pre-filled pen, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasa arvatud Lantus OptiSet pensüstli kasutusjuhendit, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for Use of Lantus SoloStar, pre-filled pen, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasa arvatud Lantus SoloStar pensüstli kasutusjuhend, sest siin on teile vajalikku teavet.
Read all of this leaflet carefully including the Instructions for Use of Toujeo OptiSet, pre-filled pen, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasa arvatud Toujeo OptiSet pensüstli kasutusjuhendit, sest siin on teile vajlikku teavet.
Read all of this leaflet carefully including the Instructions for Use of Toujeo SoloStar, pre-filled pen, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasa arvatud Toujeo SoloStar pensüstli kasutusjuhendit,sest siin on teile vajalikku teavet.
Read all of this leaflet carefully, including the Instructions for Use of Insulin Winthrop Rapid SoloStar, pre-filled pen, before you start using this medicine because it contains important information for you.
Enne ravimi kasutamist lugege hoolikalt infolehte, kaasaarvatud Insulin Human Winthrop Rapid SoloStar, eeltäidetud pen-süstli kasutusjuhendit. sest siin on teile vajalikku teavet.
Read all the following instructions carefully before using RebiDose.
Enne RebiDose’i kasutamist lugege hoolikalt kõiki järgnevaid juhiseid.
Read all the instructions carefully before using the pre-filled syringe.
Enne süsteli kasutamist lugege hoolikalt kasutusjuhendit.